Nuvalent Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	36.25	22.38	10.26	1.5	0.61
Research & Development	113.24	63.73	35.56	15.4	9.75
Operating Expenses	149.49	86.11	45.82	16.91	10.36
Operating Income	-149.49	-86.11	-45.82	-16.91	-10.36
Other Expense / Income	-23.27	-4.25	0.52	-2.35	1.45
Pretax Income	-126.22	-81.85	-46.34	-14.56	-11.81
Net Income	-126.22	-81.85	-46.34	-14.56	-11.81
Shares Outstanding (Basic)	58	50	22	3	2
Shares Outstanding (Diluted)	58	50	22	3	2
Shares Change	17.22%	128.01%	659.75%	57.23%	-
EPS (Basic)	-2.17	-1.65	-2.13	-5.08	-6.48
EPS (Diluted)	-2.17	-1.65	-2.13	-5.08	-6.48
Free Cash Flow	-99.74	-64.97	-40	-14.95	-9.64
Free Cash Flow Per Share	-1.71	-1.31	-1.84	-5.21	-5.29
EBITDA	-126.22	-81.85	-46.34	-14.56	-11.81
EBIT	-126.22	-81.85	-46.34	-14.56	-11.81

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).